And it demonstrates the beginning of our transformation from being equity-funded to becoming revenue based, with positive EPS projections all four quarters of 2021.
And neither Roth nor us know anything about how the remaining $227M we have available from the shelf registration may be utilized.
But if I'm reading Roth's estimate correctly, then it looks like the $73M we've already raised in the public offering will allow us to generate over $450M in EARNINGS next year. That's why I had previously said:
"So this $300M offering, in my opinion, should not diminish our hopes. It should fuel our hopes.
I said at the time the S-3 was announced, that it got me excited. And that remains true. We have new management that are "shovel-ready" to do their thing, and get these products commercialized world-wide."